Eupraxia Pharmaceuticals Inc. is trading 7.8% up at $6.51 in pre-market with no clear catalyst yet, extending its recent multi-day uptrend from the $5.90–$6.20 range.
- Scans of major news wires, filings, and analyst notes show no fresh company-specific announcements tied directly to this move.
- The gain may be driven by lighter pre-market liquidity or ongoing positive momentum that has not yet triggered mainstream coverage.